Pharmaceutical
Laventair Ellipta-H-C-PSUSA-00010264-202112
Advanced pharmaceutical formulation for targeted therapeutic intervention.
Dosage
Laventair Ellipta-H-C-PSUSA-00010264-202112
Strength
Laventair Ellipta-H-C-PSUSA-00010264-202112
Pack Size
Laventair Ellipta-H-C-PSUSA-00010264-202112
Form
Laventair Ellipta-H-C-PSUSA-00010264-202112
Source
European Medicines Agency
Safety Profile
Contraindications
Laventair Ellipta-H-C-PSUSA-00010264-202112
Side Effects
Laventair Ellipta-H-C-PSUSA-00010264-202112